Up till now, none of the few studies performed on TERT amplification as a mechanism of TERT re-expression and telomerase activation in thyroid cancer [5–9] has appraised the impact of TERT amplification on the clinical course (recurrence and survival) of PTC patients. This evidence concerns the gene TERT and thyroid gland carcinoma.